v3.26.1
Share-based payments (Tables)
12 Months Ended
Dec. 31, 2025
Notes and other explanatory information [abstract]  
Schedule of share purchase payment plans
     
   Number of Series A shares
Outstanding as of December 31, 2023   9,163,300(1)
Purchased during the year   5,209,713 
Exercised/vested during the year   (3,880,683)
Forfeited during the year   —   
Outstanding as of December 31, 2024   10,492,330(1)
Purchased during the year   5,668,461 
Exercised/vested during the year   (4,925,667)
Forfeited during the year   (295,821)
Outstanding as of December 31, 2025   10,939,303(1)

 

(1)These shares are presented as treasury shares in the consolidated statement of financial position as of December 31, 2025, 2024 and 2023.
Schedule of vesting period of shares granted
 
Number of Series A shares Vesting period
5,471,195 November 2026
3,578,617 November 2027
1,889,491 November 2028
10,939,303  
Schedule of retention plan (benefit) expenses
                           
   2025  2024  2023
Benefit arising from cash-settled share-based payments transactions   US$   (141)   US$   (1,131)   US$   (119)
Expense arising from equity-settled share-based payments transactions       6,413        6,309        6,048 
Total expense arising from share-based payments transactions   US$   6,272    US$   5,178    US$   5,929